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Introduc/on	  &	  Objec/ve	  
  Several	  factors	  may	  inﬂuence	  the	  decision	  to	  pursue	  nonsurgical	  modaliJes	  for	  the	  treatment	  of	  
non-­‐melanoma	  skin	  cancer	  (NMSC)	  	  
  Topical	  photodynamic	   therapy	   (PDT)	   is	   a	  non-­‐invasive	  alternaJve	   treatment	   reported	   to	  have	  a	  
high	  eﬃcacy	  in	  Bowen’s	  disease	  (BD),	  superﬁcial	  basal	  cell	  carcinoma	  (sBCC)	  and	  in	  thin	  nodular	  
BCC	  (nBCC);	  However,	  long-­‐term	  follow-­‐up	  studies	  are	  scarce	  
	  Objec/ve:	  To	  evaluate	  the	   long-­‐term	  eﬃcacy	  of	  PDT	  with	  topical	  methyl	  aminolevulinate	  (MAL)	  
for	  the	  treatment	  of	  BD	  and	  BCC	  in	  a	  dermato-­‐oncology	  department	  	  
Methods	  
  PaJents	  diagnosed	  with	  BD	  or	  BCC	  treated	  with	  MAL-­‐PDT	  from	  the	  years	  2004	  to	  2008	  	  
  Treatment	   protocol:	   tumour	   preparaJon	   before	   MAL	   160	   mg/g	   was	   applied;	   two	   MAL-­‐PDT	  
sessions	  one	  week	  apart;	  illuminaJon	  with	  red	  light	  (630	  nm),	  at	  a	  dose	  of	  37-­‐40	  J/cm2	  for	  8’20’’	  	  
  Clinical	  records	  were	  retrospecJvely	  reviewed	  
  DescripJve	  (chi	  square	  tests)	  and	  survival	  analysis	  (Kaplan-­‐Meier	  and	  Cox	  regression	  models)	  	  
Results	  
  68	  paJents	  	  
  A	  total	  of	  78	  treated	  tumours	  
Characteris/c	  
PaJents	  
	  	  	  Gender,	  male:female	   35:43	  
	  	  	  Age,	  years,	  median	  (range)	   71	  (30-­‐92)	  
Diagnosis	  (%)	  
	  	  	  BD	   31(39.7)	  
	  	  	  sBCC	   45	  (57.7)	  
	  	  	  nBCC	   2	  (2.6)	  
Biopsy	  (%)	  
	  	  	  Yes	   53	  (67.9)	  
LocalizaJon	  (%)	  
	  	  	  Face	   23	  (29.5)	  
	  	  	  Scalp	   3	  (3.8)	  
	  	  	  Trunk	   29	  (37.2)	  
	  	  	  ExtremiJes	   23	  (29.5)	  
Previous	  (pre)malignant	  lesions	  (%)	   48	  (61,5)	  
Tumour	  area	  cm2,	  median	  (range)	   5	  (0.25-­‐100)	  
Follow-­‐up,	  median	  months,	  median	   43,5	  










≤	  57	  y	  
27.9%	  
>	  57	  y	  
p	  =	  0.0036	   p	  =	  0.039	  
Both	  age	  and	  diagnosis	  were	  independent	  prognosJc	  factors	  for	  recurrence,	  with	  signiﬁcantly	  higher	  
esJmated	   recurrence	   rates	   in	  paJents	  with	  BD	   (p=0.0036)	  or	  younger	   than	  58	  years	  old	   (p=0.039).	  
Diﬀerences	   in	   recurrence	   rates	  according	   to	  sex,	   tumour	  area	  and	   localizaJon	  were	  not	  staJsJcally	  
signiﬁcant.	  
n	  =	  78	  
Results	  
Figure	  2.	  Es/mated	  /me	  to	  recurrence	  by	  diagnosis	  (A)	  and	  age	  group	  (B).	  
A	   B	  
The	  risk	  of	   recurrence	  (hazard	  raJo)	  was	  2.4	  Jmes	  higher	   in	  paJents	  with	  BD	  compared	  to	  superﬁcial	  
BCC	   (95%	   CI:1.1-­‐5.3;	   p=0.033),	   and	   2.8	   Jmes	   higher	   in	   paJents	   younger	   than	   58	   years	   old	   (95%	   CI:
1.2-­‐6.5;	  p=0.02).	  	  
Discussion	  
  In	   the	   studied	   populaJon,	   esJmated	   recurrence	   rates	   are	   higher	   than	   those	   expected	   from	  
available	  literature,	  either	  for	  sBCC	  	  and	  BD	  
  Long-­‐term	   follow-­‐up	   reports	   are	   scarce	   in	   literature	   (especially	   for	   BD),	   and	   direct	   comparison	  
between	  studies	  is	  limited	  
  Higher	   recurrence	   rates	   for	   NMSC	   and	   in	   younger	   individuals	   might	   be	   explained	   by	   paJents’	  
characterisJcs:	  acJnic	  damage	  since	  younger	  ages,	  high	  burden	  of	  malignant	  and	  pre-­‐malignant	  
skin	  disease	  (hence	  with	  follow-­‐up	  at	  an	  Oncology	  Center),	  and	  tumours	  of	  considerable	  size	  
Conclusions	  
  BD,	  as	  an	  in	  situ	  squamous	  cell	  carcinoma,	  has	  a	  higher	  tendency	  to	  recur	  than	  sBCC	  aler	  MAL-­‐
PDT	  	  
  Despite	  greater	  cosmesis	  and	  minimally	  invasive,	  PDT-­‐MAL	  might	  present	  with	  lower	  eﬃcacy	  rates	  
in	  high-­‐risk	  paJents,	  underlying	  the	  need	  for	  sustained	  long-­‐term	  follow-­‐up	  
  Further	  long-­‐term	  studies	  are	  warranted	  
